Evidence map›Paper›PMID 30321331›Full record

ArticleInflammatory bowel diseases2019

An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.

David A Muñiz Pedrogo, Jun Chen, Benjamin Hillmann, Patricio Jeraldo, Gabriel Al-Ghalith, Veena Taneja, John M Davis, Dan Knights, Heidi Nelson, William A Faubion and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Polysaccharide fromFoods (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

David A Muñiz PedrogoCenter for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota.
Jun ChenDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Benjamin HillmannDepartment of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota.
Patricio JeraldoDepartment of Surgery, Mayo Clinic, Rochester, Minnesota.
Gabriel Al-GhalithDepartment of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota.
Veena TanejaDepartment of Immunology, Mayo Clinic, Rochester, Minnesota.
John M DavisDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota.
Dan KnightsDepartment of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota.
Heidi NelsonDepartment of Surgery, Mayo Clinic, Rochester, Minnesota.
William A FaubionDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Laura RaffalsDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Purna C KashyapDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USUniversity of Minnesota · USWinnMed · USMayo Clinic in Florida · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Mechanisms of alteration of GI physiology by gut microbesR01DK114007 · NIDDK · MAYO CLINIC ROCHESTER · PI Purna C Kashyap · 2017 to 2026
$4.7M
MECHANISMS OF ALTERATION OF GASTROINTESTINAL MOTILITY BY GUT MICROBIOTAK08DK100638 · NIDDK · MAYO CLINIC ROCHESTER · PI KASHYAP, PURNA C · 2014 to 2017
$610k
Mechanisms of alteration of gastrointestinal physiology by gut microbesR03DK111850 · NIDDK · MAYO CLINIC ROCHESTER · PI KASHYAP, PURNA C · 2017 to 2018
$159k
NCATS NIH HHS UL1 TR002377NIDDK NIH HHS K08 DK100638NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK114007NIDDK NIH HHS R03 DK111850
6 · The paper itself

Abstract

backgroundInflammatory bowel diseases (IBDs) are a group of heterogeneous inflammatory conditions affecting the gastrointestinal tract. Although there is considerable evidence linking the gut microbiota to intestinal inflammation, there is limited knowledge on its potential role in the development of extraintestinal manifestations of IBD.

methodsFour groups of patients were included: IBD-associated arthropathy (IBD-A); IBD without arthropathy (IBD-N); rheumatoid arthritis (RA); and non-IBD, nonarthritis controls. DNA from stool samples was isolated and sequenced using the Illumina platform. Paired-end reads were quality-controlled using SHI7 and processed with SHOGUN. Abundance and diversity analyses were performed using QIIME, and compositional biomarker identification was performed using LEfSe.

resultsOne hundred eighty patients were included in the analysis. IBD-A was associated with an increased abundance of microbial tyrosine degradation pathways when compared with IBD-N (P = 0.02), whereas IBD-A and RA patients both shared an increased abundance of Clostridiaceae when compared with controls (P = 0.045). We found that history of bowel surgery was a significant source of variability (P = 0.001) among all IBD patients and was associated with decreased alpha diversity and increased abundance of Enterobacteriaceae (P = 0.004).

conclusionsAn increased abundance of gut microbial tyrosine degradation pathways was associated with IBD-A. An increased abundance of Clostridiaceae was shared by both IBD-A and RA patients and suggests a potentially common microbial link for inflammatory arthritis. The increased abundance of Enterobacteriaceae, previously reported in IBD, may be due to the effects of previous bowel surgery and highlights the importance of controlling for this variable in future studies.

Indexed as

Gastrointestinal MicrobiomeArthritisArthritis, RheumatoidCase-Control StudiesClostridiaceaeCross-Sectional StudiesDysbiosisFecesFemaleFollow-Up StudiesGram-Positive Bacterial InfectionsHumansInflammatory Bowel DiseasesMaleMiddle AgedPrognosisRNA, Ribosomal, 16Sgut microbiotainflammatory bowel diseaseinflammatory bowel disease–associated arthropathyrheumatoid arthritis

Identifiers

PMID30321331
PMCPMC6458525
OpenAlexW2897028238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.